Leo Pharma (a/s Leo Laboratories Ltd) v Sandoz Ltd
The Court of Appeal upheld the trial judge’s findings that Sandoz failed to prove anticipation by inevitable result, that the skilled team would not have obviously or routinely discovered the monohydrate form, and that the patent was not invalid for obviousness or anticipation. The judge’s evaluation of the evidence was amply supported and not perverse.
- Parties
- Claimant/respondent: Leo Pharma A/S; Claimant/respondent: Leo Laboratories Limited; Appellant/defendant: Sandoz Limited
- Jurisdiction
- England and Wales
- Judgment Date
- 17 November 2009
- Procedural Posture
- Civil Appeal (patents) / Appeal From High Court (patents Court) to Court of Appeal
- Outcome
- Appeal dismissed
- Legal Topics
- Patent Validity, Obviousness, Anticipation, Pharmaceutical Patents
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Leo Pharma A/S
Claimant/respondent
Leo Laboratories Limited
Claimant/respondent
Sandoz Limited
Appellant/defendant
Procedural Posture
Civil Appeal (patents) / Appeal From High Court (patents Court) to Court of Appeal
Legal Issues
- 1 Whether Leo’s EP (UK) No. 0 679 154 is invalid for anticipation or obviousness over prior art
- 2 Whether the monohydrate form of calcipotriol was inevitably produced by the prior art
- 3 Whether the patent was obvious in light of prior art and common general knowledge
Ratio Decidendi
The Court of Appeal upheld the trial judge’s findings that Sandoz failed to prove anticipation by inevitable result, that the skilled team would not have obviously or routinely discovered the monohydrate form, and that the patent was not invalid for obviousness or anticipation. The judge’s evaluation of the evidence was amply supported and not perverse.
Court Disposition
Appeal dismissed
Orders
- The appeal is dismissed; the patent is held valid.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment